Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease
Open Access
- 10 February 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Molecular Psychiatry
- Vol. 14 (11), 1004-1016
- https://doi.org/10.1038/mp.2009.10
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cellsProceedings of the National Academy of Sciences of the United States of America, 2007
- Genetic heterogeneity of Alzheimer's disease: Complexity and advancesPsychoneuroendocrinology, 2007
- GAB2 Alleles Modify Alzheimer's Risk in APOE ɛ4 CarriersNeuron, 2007
- IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factorin vivoProceedings of the National Academy of Sciences of the United States of America, 2007
- Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene databaseNature Genetics, 2007
- Increased T Cell Recruitment to the CNS after Amyloid β1–42Immunization in Alzheimer's Mice Overproducing Transforming Growth Factor-β1Journal of Neuroscience, 2006
- Evaluation of DNA microarray results with quantitative gene expression platformsNature Biotechnology, 2006
- Genetic association of ubiquilin with Alzheimer's disease and related quantitative measuresMolecular Psychiatry, 2005
- APOEɛ4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of Aβ proteinNeuropathology and Applied Neurobiology, 2003
- Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.Proceedings of the National Academy of Sciences of the United States of America, 1993